Have a personal or library account? Click to login
The Presence of Monosodium Urate Deposits in the Joints of Patients with Asymptomatic Hyperuricemia is Associated with a Higher Cardiovascular Risk, But Not with More Advanced Kidney Damage Cover

The Presence of Monosodium Urate Deposits in the Joints of Patients with Asymptomatic Hyperuricemia is Associated with a Higher Cardiovascular Risk, But Not with More Advanced Kidney Damage

Open Access
|Sep 2024

References

  1. Li L, Yang C, Zhao Y, et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and metaanalysis based on observational cohort studies. BMC Nephrol 2014; 15:122.
  2. Weiner DE, Tighiouart H, Elsayed EF, et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008; 19:1204–11.
  3. Bellomo G, Venanzi S, Verdura C, et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis 2010; 56:264-72.
  4. Bakan A, Oral A, Elcioglu OC, et al. Hyperuricemia is associated with progression of IgA nephropathy. Int Urol Nephrol 2015; 47:673-8.
  5. Zoppini G, Targher G, Chonchol M, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care 2012; 35:99-104.
  6. Iseki K, Ikemiya Y, Kinjo K, et al. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan. Clin Exp Nephrol 2004; 8:250-6.
  7. Rosolowsky ET, Ficociello LH, Maselli NJ, et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol 2008; 3:706-13.
  8. Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38:1101-6.
  9. Kohagura K, Kochi M, Miyagi T, et al. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res 2013; 36:43-9.
  10. Dimov D. New knowledge concerning hyperuricemia and gout. Rheumatology 2009; 2.
  11. Bekyarova G, Bratoeva K, Bekyarov N. Uric acid and vascular disorders in metabolic syndrome. Cardiovascular diseases 2013;44(1):40-44.
  12. Chizyński K, Rózycka M. “Hyperuricemia”. Pol. Merkur. Lekarski. 2005, 19 (113): 693-6.
  13. Backhaus M, Burmester GR, Gerber T, et al. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 2001; 60:641-9.
  14. Viazzi F, Leoncini G, Derchi LE, Pontremoli R. Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens 2014; 32:149153.
  15. Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005; 16:3553-3562.
  16. Khosla UM, Zharikov S, Finch JK, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005; 67:1739-1742.
  17. Anker SD, Leyva F, Poole-Wilson PA, et al. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart. 1997, 78:39-43.
  18. Cannon PJ, Stason WB, Demartini FE, et al. Hyperuricemia in primary and renal hypertension. N Engl J Med. 1966, 275:457-464.
  19. Corry DB, Eslami P, Yamamoto K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008; 26:269-277.
  20. Coutinho Tde A, Turner ST, Peyser PA, et al. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens. 2007; 20:83-89.
  21. McAdams MA, Maynard JW, Huizinga M, et al. Younger age at gout onset is related to obesity in a community based cohort. Arthritis Care Res (Hoboken) 2011; 63(8):1108-1114.
  22. Roubenoff R, Klag MJ, Mead LA, et al. Incidence and risk factors for gout in white men. JAMA. 1991; 266(21):3004-3007.
  23. Chen SY, Chen CL, Shen ML. Manifestations of metabolic syndrome associated with male gout in different age strata. Clin Rheumatol. 2007; 26(9):1453-1457.
  24. Gancheva R, Kundurdjiev A, Ivanova M, et al. Obesity and Echocardiographic Changes in the Different Stages of Gout [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10).
  25. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303(3):235-241.
  26. Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol. 2002; 29:1350-1355.
  27. Yamashita S, Matsuzawa Y, Tokunaga K, et al. Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes. 1986; 10(4):255-264.
  28. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab. 1994; 78(1):25-29.
  29. Rathmann W, Funkhouser E, Dyer AR, et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol. 1998; 8(4):250-261.
DOI: https://doi.org/10.2478/amb-2024-0036 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 12 - 17
Submitted on: Nov 21, 2023
Accepted on: Apr 10, 2024
Published on: Sep 7, 2024
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 R. Gancheva, A. Koundurdjiev, T. Kundurzhiev, Zl. Kolarov, P. Peteva, M. Nikolova, I. Koundurdjieva, P. Yankova, S. Monov, L. Marinchev, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.